Literature DB >> 17069353

Insulin-status-dependent modulation of FoF1-ATPase activity in rat liver mitochondria.

Samir P Patel1, Surendra S Katyare.   

Abstract

Early and late effects of alloxan diabetes and insulin treatment on mitochondrial membrane structure and function were evaluated by studying the kinetic properties of mitochondrial membrane marker enzyme FoF1-ATPase and its modulation by membrane lipid/phospholipid composition and membrane fluidity. Under all experimental conditions the enzyme displayed three kinetically distinguishable components. In 1 wk-old diabetic animals the enzyme activity was unchanged; however, K(m) and V(max) of component I increased and K(m) of component II decreased. Insulin treatment resulted in lowering of K(m) and V(max) of components II and Ill. One-mon diabetic state resulted in decreased enzyme activity, whereas insulin treatment caused hyperstimulation. K(m) of components I and II decreased together with decreased V(max) of all the components. Insulin treatment restored the K(m) and V(max) values. In late-stage diabetes the catalytic efficiency of components I and II increased; insulin treatment had drastic adverse effect. Binding pattern of ATP was unchanged under all experimental conditions. Diabetic state resulted in progressive decrease in energy of activation in the low temperature range (E(L)). Insulin treatment lowered the energy of activation in the high temperature range (E(H)) without correcting the E(L) values. The phase transition temperatures increased in diabetic state and were not corrected by insulin treatment. Long-term diabetes lowered the total phospholipid content and elevated the cholesterol content; insulin treatment had partial restorative effect. The membrane fluidity decreased in general in diabetic condition and was not corrected by insulin treatment at late stage. Regression analysis studies suggest that specific phospholipid classes and/or their ratios may play a role in modulation of the enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17069353     DOI: 10.1007/s11745-006-5020-y

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  38 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

3.  Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.

Authors:  M Anello; R Lupi; D Spampinato; S Piro; M Masini; U Boggi; S Del Prato; A M Rabuazzo; F Purrello; P Marchetti
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

4.  Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

Authors:  Y Ido; A Vindigni; K Chang; L Stramm; R Chance; W F Heath; R D DiMarchi; E Di Cera; J R Williamson
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

5.  Influence of insulin status on extra-mitochondrial oxygen metabolism in the rat.

Authors:  J G Satav; K R Dave; S S Katyare
Journal:  Horm Metab Res       Date:  2000-02       Impact factor: 2.936

Review 6.  ATP synthases. Structure, reaction center, mechanism, and regulation of one of nature's most unique machines.

Authors:  P L Pedersen; L M Amzel
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

7.  Diabetes induces metabolic adaptations in rat liver mitochondria: role of coenzyme Q and cardiolipin contents.

Authors:  Fernanda M Ferreira; Raquel Seiça; Paulo J Oliveira; Pedro M Coxito; António J Moreno; Carlos M Palmeira; Maria S Santos
Journal:  Biochim Biophys Acta       Date:  2003-10-15

Review 8.  Microvascular complications of impaired glucose tolerance.

Authors:  J Robinson Singleton; A Gordon Smith; James W Russell; Eva L Feldman
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

9.  Effect of diabetes mellitus and different treatments on plasma and erythrocyte phospholipid fatty acid composition in type 2 diabetics.

Authors:  Yanik Rodríguez; Armand B Christophe
Journal:  Ann Nutr Metab       Date:  2004-10-01       Impact factor: 3.374

Review 10.  Mitochondrial diabetes: molecular mechanisms and clinical presentation.

Authors:  J Antonie Maassen; Leen M 'T Hart; Einar Van Essen; Rob J Heine; Giel Nijpels; Roshan S Jahangir Tafrechi; Anton K Raap; George M C Janssen; Herman H P J Lemkes
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

View more
  5 in total

1.  Effect of alloxan diabetes and subsequent insulin treatment on temperature kinetics properties of succinate oxidase activity in rat kidney mitochondria.

Authors:  Samir P Patel; Surendra S Katyare
Journal:  J Membr Biol       Date:  2007-03-08       Impact factor: 1.843

2.  The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria.

Authors:  Patrizia Zaccagnino; Susanna D'Oria; Luigi Luciano Romano; Almerinda Di Venere; Anna Maria Sardanelli; Michele Lorusso
Journal:  J Bioenerg Biomembr       Date:  2012-03-22       Impact factor: 2.945

3.  Diabetic modulation of the temperature kinetics properties of cytochrome oxidase activity in rat brain mitochondria.

Authors:  Surendra S Katyare; Samir P Patel; Hiren R Modi
Journal:  Neurochem Res       Date:  2007-08-25       Impact factor: 3.996

4.  Insulin status-dependent alterations in lipid/phospholipid composition of rat kidney microsomes and mitochondria.

Authors:  Samir P Patel; Surendra S Katyare
Journal:  Lipids       Date:  2006-09       Impact factor: 1.646

5.  Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action.

Authors:  Lewis A Quayle; Maria G Pereira; Gerjan Scheper; Tammy Wiltshire; Ria E Peake; Issam Hussain; Carol A Rea; Timothy E Bates
Journal:  Oncotarget       Date:  2017-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.